510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K946146Substantially Equivalent

Cardiospex(tm) Liquid Ckmb/ld-1 Immunoinhibition

Clinical Controls, Inc., Grover Beach CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K946146 is the FDA 510(k) clearance record for CARDIOSPEX(TM) LIQUID CKMB/LD-1 IMMUNOINHIBITION, a class I device, cleared for Clinical Controls, Inc. on under FDA product code JJT (Enzyme Controls (Assayed And Unassayed)). FDA records list 18 510(k) clearances for Clinical Controls, Inc., from to . As of , FDA records show no recalls naming K946146.

Clearance record

Decision date
Received
(39 days to decision)
Product code
JJT Enzyme Controls (Assayed And Unassayed)
Regulation
21 CFR 862.1660
Device class
Class I
Review panel
Clinical Chemistry
Applicant
Clinical Controls, Inc. 750 Farroll Rd., Grover Beach CA
510(k) summary
Statement
Third party review
No

Clearances, product code JJT

Trailing 12 months

FDA records hold no clearances under product code JJT in the trailing twelve months.

FDA records show no clearances under product code JJT in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JJT, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260